Literature DB >> 17670455

Histological findings induced by different energy sources in experimental atrial ablation in sheep.

Heike Aupperle1, Nicolas Doll, Thomas Walther, Cris Ullmann, Heinz-Adolf Schoon, Friedrich Wilhelm Mohr.   

Abstract

The aim of this study was a detailed comparative investigation of acute cardiac alterations induced by different energy sources and approaches in a sheep model. Experiments were performed on 39 sheep. Circular lesions were created endo- or epicardially in the left atrium and at the pulmonary veins using different energy sources: cryo, microwave, laser and unipolar or bipolar radiofrequency (RF). Electrophysiological examinations were performed immediately post treatment and 2 h after ablation to prove conduction block. Altered areas of the atria and pulmonary veins were investigated histopathologically. Endocardial ablation resulted in transmural lesions, confirmed by electrophysiological examinations. However, endocardial microwave and laser induced intensive thrombus formation, whereas radiofrequency and cryoablation induced more circumscribed necrosis and led to little endocardial thrombi. Epicardial cryoablation and microwave energy were not successful in acute phase in 8 of 9 animals. In contrast, epicardial bipolar RF was efficient and resulted in well demarcated slim lesion lines but induced marked thrombus formation. It can be summarized that surgical ablation techniques using different energy sources and approaches in this acute animal model resulted in different electrophysiological effectiveness and histomorphological lesions. Further mid and long term studies are necessary to confirm these results.

Entities:  

Year:  2005        PMID: 17670455     DOI: 10.1510/icvts.2005.109413

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

1.  The challenge of defining procedural endpoints for the surgical treatment of atrial fibrillation.

Authors:  Niv Ad
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

2.  Direct thermography-a new in vitro method to characterize temperature kinetics of ablation catheters.

Authors:  M Fiek; F Gindele; C von Bary; D Muessig; A Lucic; E Hoffmann; C Reithmann; G Steinbeck
Journal:  J Interv Card Electrophysiol       Date:  2013-07-14       Impact factor: 1.900

Review 3.  Is Cryo a Better Energy Source Than Radiofrequency for AF Ablation in Preventing Esophageal Injury?

Authors:  Pawan K Arora; James C Hansen; Rakesh Latchamsetty; Boaz Avitall
Journal:  J Atr Fibrillation       Date:  2009-04-01

4.  Spectroscopic photoacoustic imaging of radiofrequency ablation in the left atrium.

Authors:  Sophinese Iskander-Rizk; Pieter Kruizinga; Antonius F W van der Steen; Gijs van Soest
Journal:  Biomed Opt Express       Date:  2018-02-23       Impact factor: 3.732

5.  Outcome of paroxysmal atrial fibrillation ablation with the cryoballoon using two different application times: the 4- versus 3-min protocol.

Authors:  Florian Straube; Uwe Dorwarth; Stefan Hartl; Benedikt Bunz; Michael Wankerl; Ullrich Ebersberger; Ellen Hoffmann
Journal:  J Interv Card Electrophysiol       Date:  2015-12-23       Impact factor: 1.900

6.  Right minithoracotomy versus conventional median sternotomy for patients undergoing mitral valve surgery and Cox-maze IV ablation with entirely bipolar radiofrequency clamp.

Authors:  Zhaolei Jiang; Min Tang; Nan Ma; Hao Liu; Fangbao Ding; Chunrong Bao; Ju Mei
Journal:  Heart Vessels       Date:  2018-02-02       Impact factor: 2.037

7.  Treatment of lone atrial fibrillation: minimally invasive pulmonary vein isolation, partial cardiac denervation and excision of the left atrial appendage.

Authors:  Randall K Wolf
Journal:  Ann Cardiothorac Surg       Date:  2014-01

8.  Early recurrence after cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: mechanism and implication in long-term outcome.

Authors:  Yue Wei; Yangyang Bao; Changjian Lin; Yun Xie; Qingzhi Luo; Ning Zhang; Liqun Wu
Journal:  BMC Cardiovasc Disord       Date:  2022-09-07       Impact factor: 2.174

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.